S&P 500 Consumer Staples Sector SEC Filings — May 13, 2026

USA S&P 500 Consumer Staples

By Gunpowder Editorial ·

20 high priority 30 medium priority 50 total filings analysed

Executive Summary

Across 50 SEC filings primarily from Q1 2026 10-Qs, 8-Ks, and 13F-HRs (despite Consumer Staples focus, spanning diverse sectors with staples like Colgate-Palmolive, Coca-Cola Consolidated, Kroger, and Newell Brands), overarching themes include robust revenue growth in 12/18 reporting companies averaging +72% YoY (e.g., Momentus +899%, Motorsport +129%, Accelerant +53.5%) offset by widening net losses in 10/18 (avg +25% YoY deeper) due to op-ex inflation (+40% avg YoY).

Staples sector showed governance stability with 100% proposal approvals at Colgate, Coca-Cola Cons, and Newell AGMs, alongside Kroger's strong 2025 recap (9% EPS growth, eCommerce profitable). Mixed sentiment dominated (14/50 filings), with positive AGMs (8/12) and neutral 13Fs (9/9 no changes). Forward guidance emerged bullish for Accelerant (FY EWP $5.2B+), ClearPoint ($52-56M rev), highlighting catalysts amid capex and M&A (e.g., Allegiant-Sun Country $140M synergies). Capital allocation leaned shareholder-friendly (buybacks at Accelerant, distributions +20% at New Mountain), but cash burns persisted in biotech/small caps. Portfolio-level: Margin expansion rare (ClearPoint +400bps to 64%), outliers in revenue surges signal growth pockets vs sector stagnation risks.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-Q · 13F · 8-K · DEF 14A · 10-K · DEFA14A

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from May 12, 2026.

Investment Signals (12)

  • Service revenue exploded +899% YoY to $3.215M, gross profit to $1.817M, despite loss widening; dilutive securities up but stable options

  • Total investment income +14% YoY to $11.4M, net investment income +23% to $8.9M, distributions +20% YoY to $8.9M

  • Quarterly revenue +13% YoY to $2.223M, operating income turned positive $64k vs -$187k loss, six-month net income $111k vs -$160k

  • Revenues +53.5% YoY to $273.3M, adjusted EBITDA $66.1M, repurchased $11M shares; FY guidance raised EWP $5.2B+, Adj EBITDA $285M

  • Record Q1 revenue +43% YoY to $12.1M (neurosurgery +80%, capital +177%), gross margin +400bps to 64%; FY guide $52-56M

  • Revenue +129% YoY to $4.03M, gross profit +172% to $3.51M, operating income $1.06M vs -$93k loss; Adj EBITDA +150% to $1.5M

  • Insight Molecular Diagnostics (IMDX) (BULLISH)

    Cash +144% to $29.4M post $24.6M offering, FDA dialogues for 2026 auth, ISO cert, head-to-head data presented

  • 2026 AGM all 11 directors elected (For >90%), exec comp approved 99%+, PwC ratified; strong governance

  • AGM all 10 directors elected (For 92-99%), exec comp 91%+, PwC ratified 99%; rejected DEI/stockholder props

  • Kroger Co (BULLISH)

    2025 perf doubled identical sales ex-fuel, +9% EPS, $16B eCommerce profitable; 2026 plans 30% new stores growth

  • AGM all 8 directors elected 87-98%, Say-on-Pay 78%, 2026 Incentive Plan 93%, PwC 99%

  • Acquired Sun Country, combined 195 aircraft/175 cities, $140M annual synergies in 3yrs, EPS accretive FY1

Risk Flags (10)

Opportunities (10)

  • Q2 EWP $1.27-1.32B (+12-16% implied YoY), FY third-party direct $2.3B+, Adj EBITDA $285M; premium growth 16% YoY

  • IRRAS integration adds $2.3M rev Q1, biologics steady $4.8M; FY rev guide $52-56M (+15-25% YoY) at improving 64% margins

  • Op income positive $1.06M vs loss, cash ops +$0.5M/month, $3M Citibank LOC to 2028, Le Mans V1.3 released

  • Allegiant Travel/M&A (OPPORTUNITY)

    Sun Country acquisition $140M synergies/3yrs, fleet 195 aircraft, EPS accretive FY1, no immediate disruptions

  • Kroger/Expansion (OPPORTUNITY)

    2026 30% new stores growth, efficiency/tech investments post strong 2025 (doubled sales ex-fuel, eComm profitable)

  • Resort ops +15% YoY driving rev +13%, op income positive, assets +4% to $31.6M

  • Equity turned positive $22.3M from -$6.8M deficit, rev +65% YoY Q3/$13.5M 9M, $10M notes +$5.9M equity

  • IMDX/Commercialization (OPPORTUNITY)

    GraftAssureDx FDA target 2026, Quest agreement, TÜV ISO cert, RUO sales to Swiss/APAC, $29M cash to 2Q27

  • Distributions +20% YoY, business svcs 33.9%/software 30.8% portfolio, cash ops improved

  • 100% insulin independence in 10/12 pts, FDA Orphan Drug liver tx, eGFR +10% in 24mo data, cash to 2Q27

Sector Themes (6)

  • Revenue Acceleration in Services/Tech

    9/18 10-Qs showed +50%+ YoY rev growth (Momentus 899%, Motorsports 129%, Accelerant 53%, ClearPoint 43%), outpacing staples stability; implies small-cap outperformance vs S&P Staples avg ~3-5% [Growth Rotation]

  • Persistent Loss Widening Despite Growth

    10/15 loss-reporting firms saw net losses +20-500% YoY (Eledon +500%, Momentus +54%) from op-ex +40% avg (personnel/R&D); staples AGMs contrast with clean governance [Expense Discipline Needed]

  • Strong AGM Approvals in Staples

    5/5 staples-related AGMs (Colgate, Coca-Cola Cons, Kroger, Newell, Kronos proxy) passed directors/exec comp/auditors >85-99% For; rejected stockholder props, signaling board conviction [Governance Strength]

  • Capital Return Focus

    Distributions/buybacks up (NewMtn +20%, Accelerant $11M shares); staples like Newell approve new incentive plans; vs cash burns in biotech ($8M/quarter avg) highlights return vs growth divergence [Shareholder Yield]

  • Neutral Institutional 13Fs

    9/9 13Fs (Carnegie Mellon, Measured Wealth, etc.) no changes QoQ, sole discretion, diversified ETFs/stocks; energy/mining tilt in some (Aegis, Kopernik +shares miners) vs staples underweight [Steady Hands]

  • Guidance Positivity Emerging

    4 firms raised FY guides (Accelerant $285M EBITDA, ClearPoint $52-56M rev); staples forward via Kroger 30% stores/2026; builds Q2 catalyst calendar amid Q1 mixed [Forward Momentum]

Watch List (8)

  • Virtual AGM June 25 2026 vote on 10 directors, exec comp, auditors, LTIP; monitor 2026 store growth guidance post strong 2025 [June 25]

  • Virtual June 4 2026 on Class B increase to 2.5B shares, reverse split 1:50, CEO shares issuance; Majority Holders vote FOR [June 4]

  • Virtual June 25 2026 elect 8 directors, exec comp, auditors; watch indep chair prop (board AGAINST) [June 25]

  • Virtual June 25 2026 elect Class II directors, auditors, exec comp; record Apr 30, 341M Class A shares [June 25]

  • FY rev guide $52-56M, monitor IRRAS integration post Q1 $2.3M contrib, biologics growth [Q2 Earnings TBD]

  • EWP $1.27-1.32B Q2, watch third-party direct premium mix (41% Q1 up from 19%) for FY $5.2B beat [Q2 Earnings TBD]

  • Acting CFO Vivek Garg post termination; monitor severance, Q1 results impact [Earnings Call TBD]

  • IMDX/FDA Progress
    👁

    GraftAssureDx auth target late 2026, CE Mark soon, GALACTIC registry 34 centers; $29M cash runway [H2 2026]

Filing Analyses (50)
Momentus Inc. 10-Q mixed materiality 8/10

13-05-2026

Momentus Inc. reported service revenue of $3,215 thousand for Q1 2026, a 899% YoY increase from $322 thousand, driving gross profit to $1,817 thousand. However, operating expenses rose 62% to $10,509 thousand, resulting in an operating loss of $8,692 thousand and net loss of $9,480 thousand, wider than the prior year's net loss of $6,172 thousand. Share-based compensation remained elevated at $322 thousand, matching total stock compensation expense.

  • · Options outstanding stable at 2,424 as of March 31, 2026, with weighted-average exercise price $632.86.
  • · RSUs outstanding increased to 126,643 from 42,604 as of December 31, 2025.
  • · Total dilutive securities rose to 2,359,385 in Q1 2026 from 289,409 in Q1 2025.
  • · Cash paid for interest $65 thousand; operating lease payments $419 thousand in Q1 2026.
CARNEGIE MELLON UNIVERSITY 13F-HR neutral materiality 4/10

13-05-2026

Carnegie Mellon University filed its quarterly 13F-HR on May 13, 2026, for the period ended March 31, 2026, reporting total holdings value of $64,341,510 across six positions, all with sole voting power. The largest holdings are Invesco QQQ Trust Unit Ser 1 at $35,269,161 (61,106 shares) and Duolingo Inc Cl A Com at $29,059,816 (294,814 shares). Smaller positions include InnSuites Hospitality Tr Sh Ben Int ($10,101, 10,000 shares), Longevity Health Hldgs Inc Com (combined $1,313, 4,482 shares across two entries), and Axe Compute Inc Com ($1,119, 691 shares).

  • · All reported holdings have sole voting power and no investment discretion or other manager shares.
  • · Filer CIK: 0001039067, SEC File Number: 028-21801.
  • · Business address: 5000 Forbes Avenue, Pittsburgh, PA 15213.
Measured Wealth Private Client Group, LLC 13F-HR neutral materiality 3/10

13-05-2026

Measured Wealth Private Client Group, LLC filed its 13F-HR on May 13, 2026, disclosing 726 investment positions held as of March 31, 2026, exercised with sole investment discretion and voting authority. Top holdings include Vanguard Whitehall Fds High Div Yld at $23899666, SPDR Series Trust State Street SPD (78464A508) at $23436219, Select Sector SPDR Tr State Street HEA at $17958291, United Parcel Svcs Inc Cl B at $16626810, and Select Sector SPDR Tr State Street TEC at $15648562. The portfolio features a mix of ETFs and individual stocks across sectors with no reported changes, options, or shared discretion.

  • · Conformed period of report: 2026-03-31
  • · Filed as of date: 2026-05-13
  • · All positions reported as SH (shares) with SOLE investment discretion and voting authority
  • · No put/call positions or other investment discretion reported
  • · Business address: 303 Islington Street, Portsmouth, NH 03801
New Mountain Guardian IV Income Fund, L.L.C. 10-Q mixed materiality 6/10

13-05-2026

For the three months ended March 31, 2026, New Mountain Guardian IV Income Fund reported total investment income of $11,427 thousand, up 14% YoY from $10,032 thousand, driven by higher interest income, with net investment income increasing 23% YoY to $8,925 thousand. However, net unrealized depreciation of $7,363 thousand (vs $843 thousand YoY) and realized losses of $264 thousand resulted in a net operations increase of only $1,298 thousand, down 80% YoY from $6,389 thousand, leading to members' capital declining to $501,846 thousand (down 1.5% QoQ) and NAV per unit falling to $9.79 from $9.94 QoQ. Distributions declared totaled $8,865 thousand, up from $7,394 thousand YoY.

  • · Cash and cash equivalents declined to $24,395 thousand from $35,000 thousand QoQ.
  • · Total liabilities increased to $14,080 thousand from $11,287 thousand QoQ.
  • · Net cash used in operating activities improved to $1,210 thousand used from $9,765 thousand used YoY.
  • · First Lien investments showed net unrealized depreciation of $4,041 thousand in Q1 2026.
  • · Investment purchases totaled $25,682 thousand in Q1 2026, with proceeds from sales/paydowns at $16,452 thousand.
Santa Clara Valley Transportation Authority 13F-HR neutral materiality 4/10

13-05-2026

Santa Clara Valley Transportation Authority filed its 13F-HR on May 13, 2026, disclosing holdings as of March 31, 2026, in four iShares ETFs with a total portfolio value of $120,255,822. The holdings include iShares Core MSCI Emerging Markets ETF valued at $44,022,224, iShares 1-3 Year Treasury Bond ETF at $27,209,870, iShares USD Investment Grade Corporate Bond ETF at $24,691,682, and iShares Broad USD High Yield Corporate Bond ETF at $24,332,046.

  • · All holdings reported as sole ownership.
  • · Filing signed in San Jose, CA on May 13, 2026.
  • · Business address: 3331 North First Street (Bldg. C-2), San Jose, CA 95134.
Godshalk Welsh Capital Management, Inc. 13F-HR neutral materiality 3/10

13-05-2026

Godshalk Welsh Capital Management, Inc. filed its 13F-HR on May 13, 2026, disclosing 129 equity positions held as of March 31, 2026, all with sole voting authority and no shared or none authority positions. Top holdings by market value include Apple Inc. (8197925 USD, 32302 shares), Microsoft Corporation (7334919 USD, 19815 shares), and Alphabet Inc. Cl A (5139847 USD, 17874 shares), alongside a diversified mix of large-cap stocks, ETFs, and fixed-income oriented iShares iBonds ETFs. No prior period comparisons are available in the filing.

  • · Report period end date: 2026-03-31
  • · Filing as of date: 2026-05-13
  • · All 129 positions held as sole discretionary accounts
  • · Portfolio includes significant allocations to short-term municipal and corporate bond ETFs (e.g., iShares iBonds series totaling over 1M USD each in multiple maturities)
New Mountain Guardian IV Income Fund, L.L.C. 8-K neutral materiality 6/10

13-05-2026

New Mountain Guardian IV Income Fund, L.L.C. disclosed its consolidated schedule of investments as of March 31, 2026, classifying portfolio investments into 11 industry types with sub-classifications for internal monitoring. Business Services subtotal is 33.9% of total investments at fair value, Software subtotal 30.8%, Financial Services & Technology 15.1%, and Healthcare 10.1%, with smaller allocations to Consumer Services (4.6%), Education (3.2%), and others totaling 100%. No prior period comparisons or performance metrics were provided.

  • · Disclosure furnished under Item 7.01 and not deemed 'filed' for liability purposes
  • · Portfolio companies assigned sub-classifications within 11 industry types for internal monitoring
Kopernik Global Investors, LLC 13F-HR positive materiality 6/10

13-05-2026

Kopernik Global Investors, LLC disclosed $1.43B in total 13F portfolio value as of March 31, 2026 (Q1 2026), across 31 holdings, with top positions in Seabridge Gold Inc ($208M), Range Resources Corp ($189M), KT Corp ($114M), Nutrien Ltd ($107M), and Expand Energy Corporation ($89M). The firm increased shares in most positions quarter-over-quarter (QoQ), including +616,756 shares in Northern Dynasty Minerals Ltd (+1.9%), +379,221 shares in International Tower Hill Mines (+2.2%), and +263,549 shares in NovaGold Resources Inc (+4.2%), while positions like AbbVie, Amgen, Apple, and AutoZone put options and Newmont Corp remained flat at 0% change. No share reductions were reported in the listed holdings.

  • · Portfolio heavily weighted toward mining and energy stocks (e.g., Seabridge Gold, Northern Dynasty Minerals, NovaGold Resources, Range Resources).
  • · All reported share changes involved additions (no removals), with REM column at 0 across positions.
  • · Put options held in AbbVie Inc (4,600 shares), Amgen Inc (4,200 shares), Apple Inc (5,000 shares), and AutoZone Inc (400 shares), unchanged QoQ.
RARE ELEMENT RESOURCES LTD 10-Q mixed materiality 7/10

13-05-2026

Rare Element Resources Ltd reported a narrowed net loss of $2,133 for Q1 2026 compared to $2,395 in Q1 2025, driven by lower operating expenses of $2,340 versus $2,672 YoY, while cash and total assets surged to $47,141 and $52,627 respectively from $19,315 and $24,120 at year-end 2025 due to a $30,478 rights offering. However, net cash used in operating activities increased to $2,725 from $2,269 YoY, and the accumulated deficit grew to $183,123 from $180,990. Shares outstanding rose to 645,368,390 from 516,134,712 QoQ amid the financing.

  • · Exploration and evaluation expenses: $1,719 in Q1 2026 vs $1,877 in Q1 2025
  • · Corporate administration expenses: $580 in Q1 2026 vs $750 in Q1 2025
  • · Non-operating income: $207 in Q1 2026 vs $277 in Q1 2025
  • · Accumulated deficit: $183,123 as of March 31, 2026
Monashee Investment Management LLC 13F-HR neutral materiality 9/10

13-05-2026

Monashee Investment Management LLC filed its 13F-HR on May 13, 2026, disclosing 45 equity and debt holdings as of March 31, 2026, with a total portfolio market value of $183.8 billion. Top positions include Terns Pharmaceuticals Inc. ($15.8B, 300,000 shares), Nextera Energy Inc. Unit 02/15/2029 ($15.2B, 299,970 shares), Medline Inc. ($13.4B, 300,000 shares), NRG Energy Inc. ($12.4B, 85,000 shares), Forgent Power Solutions Inc. ($10.2B, 350,000 shares), and Solid Biosciences Inc. ($10.2B, 1,420,295 shares). No prior period comparisons or changes are provided in the filing.

  • · All reported holdings are held on a sole discretionary basis
  • · SEC file number: 028-16854
  • · Investment adviser CIK: 000163148
PISMO COAST VILLAGE INC 10-Q mixed materiality 7/10

13-05-2026

Pismo Coast Village Inc reported results for the three and six months ended March 31, 2026, with quarterly revenue increasing 13% YoY to $2,223,000 from $1,966,000, driven by 15% growth in resort operations to $2,031,000, while achieving operating income of $64,000 versus a $187,000 loss prior year. For the six months, revenue rose 13% to $4,536,000, with net income of $111,000 versus a $160,000 loss, but retail operations declined 4% to $279,000 and property lease income fell 11% to $101,000, resulting in a modest six-month operating loss of $14,000. Total assets grew to $31,649,000 from $30,529,000 at September 30, 2025.

  • · Net cash provided by operating activities was $1,543,000 for six months ended March 31, 2026, slightly down from $1,545,000 prior year.
  • · Capital expenditures of $213,000 in six months ended March 31, 2026, up from $113,000.
  • · Property and equipment, net decreased slightly to $16,573,000 from $16,588,000.
  • · Customer deposits increased to $3,977,000 from $2,596,000.
Classover Holdings, Inc. DEF 14A neutral materiality 8/10

13-05-2026

Classover Holdings, Inc. is soliciting proxies for its virtual Annual Meeting on June 4, 2026, to vote on five proposals: (1) increasing authorized Class B Common Stock from 40,000,000 to 2,500,000,000 shares; (2) issuing Class B shares to Solana Growth Ventures LLC per the December 29, 2025 Exchange Agreement to comply with Nasdaq rules; (3) approving a reverse stock split of 1-for-2 to 1-for-50 on Class A and Class B shares; (4) authorizing up to 5,000,000 additional Class A shares to CEO Hui Luo at 150% of prevailing market price; and (5) electing five board members. As of the May 8, 2026 record date, 130,701 Class A shares, 6,787,870 Class B shares, and 522,801 Series A Preferred shares are outstanding. Directors, officers, and affiliates (Majority Holders) control 2.5% of common stock but 32.9% of voting power and intend to vote FOR most proposals.

  • · Annual Meeting is virtual at https://www.cstproxy.com/classover/2026, 10:00 a.m. Eastern time.
  • · Proxy material requests must be received by May 27, 2026.
  • · Board recommends voting FOR all proposals; Ms. Luo will vote her shares per public holders' majority on Class A Issuance Proposal.
  • · Quorum requires majority of outstanding Common Stock; all proposals are non-routine, no broker non-votes expected.
KELLY SERVICES INC 8-K neutral materiality 6/10

13-05-2026

Kelly Services, Inc. adopted an Amended and Restated Certificate of Incorporation, effective via 8-K filing on May 13, 2026, authorizing 110,000,000 shares at $1.00 par value, comprising 100,000,000 non-voting Class A Common Stock and 10,000,000 voting Class B Common Stock convertible 1:1 into Class A. Class B holders receive equal dividends (with protections), preemptive rights on voting stock, and equal liquidation rights; the board consists of 5-11 directors elected annually, removable with or without cause by majority vote, with no cumulative voting. Additional provisions limit director/officer liability, allow action by written consent, and restrict special stockholder meetings to Class B majority holders.

  • · Registered office: 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.
  • · Original certificate filed August 27, 1952.
  • · Class B conversion requires surrender of certificates to corporation or Transfer Agent; corporation covers issuance taxes.
  • · Notice of reclassifications/mergers must be provided 30 days prior to Class A record date for Class B holders.
Eledon Pharmaceuticals, Inc. 8-K mixed materiality 8/10

13-05-2026

Eledon Pharmaceuticals reported strong clinical progress in Q1 2026, including 100% insulin independence in 10 of 12 type 1 diabetes patients treated with tegoprubart post-islet transplantation, FDA Orphan Drug designation for liver transplantation, and improved eGFR from 67.0 to 74.2 mL/min/1.73 m² in 24-month Phase 1b kidney transplant data. However, cash and equivalents declined 17% QoQ to $111.1M from $133.3M, R&D expenses rose 27% YoY to $17.2M from $13.5M, and net loss widened to $39.0M from $6.5M YoY, driven by a $19.0M non-cash warrant liability loss. The company expects cash to fund operations into 2Q 2027 amid planned Phase 3 initiation and new trials.

  • · No episodes of biopsy-proven acute rejection, graft loss, death, new-onset diabetes mellitus, or de novo donor-specific antibody formation in Phase 1b 24-month data.
  • · Excluding non-cash warrant changes, adjusted net loss was $20.1M in Q1 2026 vs $16.6M in Q1 2025.
  • · Total assets $146.667M as of March 31, 2026 vs $169.009M as of December 31, 2025.
  • · Warrant liabilities increased to $30.378M as of March 31, 2026 from $11.416M as of December 31, 2025.
Accelerant Holdings 8-K mixed materiality 9/10

13-05-2026

Accelerant Holdings reported first quarter 2026 Exchange Written Premium of $1,138.7 million, up 16% year-over-year from $985.2 million, with total revenues surging 53.5% to $273.3 million driven by strong growth in ceding and direct commission income. However, pre-tax income declined sharply to $2.0 million from $15.5 million, resulting in a net loss of $4.1 million versus a $7.8 million profit in the prior year, though adjusted EBITDA improved to $66.1 million and adjusted net income rose 118% to $37.7 million. The company repurchased 828,333 Class A common shares for $11 million and issued positive guidance for Q2 and full-year 2026.

  • · Third-Party Direct Written Premium accounted for 41% of Exchange Written Premium in Q1 2026 (up from 19% YoY)
  • · Q2 2026 guidance: Exchange Written Premium $1.27B to $1.32B; Adjusted EBITDA $60M to $66M
  • · Full year 2026 guidance: Exchange Written Premium at least $5.2B; Third-Party Direct Written Premium at least $2.3B; Adjusted EBITDA at least $285M
  • · New independent Board members elected: David Talach and Simon Wainwright
  • · Conference call scheduled for May 14, 2026 at 8:00 a.m. ET
UNITED PARCEL SERVICE INC 8-K neutral materiality 5/10

13-05-2026

Kevin M. Warsh resigned from the Board of Directors of United Parcel Service, Inc. (UPS) effective May 13, 2026, upon his confirmation by the U.S. Senate as Chairman of the Board of Governors of the Federal Reserve System. This resignation was automatic as previously disclosed in a Form 8-K filed on February 6, 2026, and was not due to any disagreement with the Company's operations, policies, or practices.

  • · Resignation advised in prior Form 8-K on February 6, 2026
MONOGRAPH WEALTH ADVISORS, LLC 13F-HR neutral materiality 6/10

13-05-2026

Monograph Wealth Advisors, LLC filed Form 13F-HR on May 13, 2026, reporting its equity holdings as of March 31, 2026, with a portfolio heavily weighted toward Dimensional Fund Advisors ETFs. Top holdings include DFA US Core Equity 2 ETF valued at $265730747 and DFA World ex US Core Equity 2 ETF at $209488060, followed by iShares Core S&P 500 ETF ($35820077), Apple Inc. ($31313754), and DFA US Targeted Value ETF ($45695307). No period-over-period comparisons or performance metrics are provided in the filing.

  • · Filer CIK: 0001776588
  • · Business address: 1230 Rosecrans Ave, Suite 425, Manhattan Beach, CA 90266
  • · Phone: 3104967377
  • · SEC file number: 028-21724
  • · Report period end date: 2026-03-31
  • · Filing date: 2026-05-13
APPLIED OPTOELECTRONICS, INC. 8-K positive materiality 8/10

13-05-2026

Applied Optoelectronics, Inc. (AAOI) entered into a lease agreement dated May 8, 2026, with Hightower Phase I Owner, LLC for a 163,930 rentable square foot building (Hightower Business Park - Phase I – Building 1) at 6000 McHard Road, Houston, Texas 77053, plus an adjacent 3.34 acre unimproved Reserve Tract 4, for general industrial/warehouse and light manufacturing use over a 123-month term. Basic rent for the building is $0 for months 1-3, then escalates from $104,915.20 monthly ($0.64 per sq ft) in months 4-15 to $146,127.30 ($0.89 per sq ft) in months 112-123; Reserve Tract 4 rent starts at $6,680 monthly from month 4, rising to $9,303.99. No early performance metrics are available, but the lease includes a $391,613.18 security deposit and anticipated substantial completion around November 1, 2026.

  • · Commencement Date: Earliest of Tenant occupancy for business, Substantial Completion of Work (per Exhibit D), or date Work would have been Substantially Completed absent Tenant Delays.
  • · Estimated Delivery Date: November 1, 2026; Outside Delivery Date: January 1, 2027 (extended for Tenant Delays or Force Majeure).
  • · Tenant’s Proportionate Share: 100%.
  • · Permitted Use: General industrial/warehouse for light manufacturing, receiving, storing, shipping, and wholesale sales.
  • · Exclusive rights: 24/7 use of loading facilities, trash removal area, and designated parking areas.
Insight Molecular Diagnostics Inc. 8-K mixed materiality 8/10

13-05-2026

IMDX reported minimal Q1 2026 revenues of $32,000 from laboratory services, essentially pre-revenue for kitted products, with a net loss of $4.3 million ($0.12 per share) and adjusted net loss of $9.6 million ($0.28 per share), amid ongoing cash burn of $8.3 million in free cash flow. Progress toward GraftAssureDx commercialization includes productive FDA dialogues targeting authorization later in 2026, initial RUO kit sales to a Swiss hospital and expected APAC order, and GALACTIC registry engagement with 34 U.S. centers interested including a top-10 Northeast kidney center. Cash balance was $29.4 million following $24.6 million net proceeds from a $26.0 million registered direct offering.

  • · Q1 2026 operating expenses included $615K non-cash stock-based compensation and $610K non-cash depreciation/amortization.
  • · TÜV SÜD ISO 13485 certification received February 26, 2026; targeting CE Mark under UK IVDD soon.
  • · Head-to-head data vs competitors presented at EFI2026, with prior data accepted for publication in Clinical Chemistry.
  • · 34.5 million weighted average shares outstanding in Q1 2026, reflecting pre-funded warrants.
Elevance Health, Inc. 8-K positive materiality 6/10

13-05-2026

Elevance Health, Inc. held its Annual Meeting of Shareholders on May 13, 2026, with 194,441,339 shares of common stock represented, constituting a quorum. Shareholders elected directors Gail K. Boudreaux, Robert L. Dixon, Jr., and Deanna D. Strable to three-year terms expiring in 2029, approved the advisory vote on executive compensation, and ratified Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026. A shareholder proposal requesting an independent study on prohibiting corporate contributions to partisan 527 tax-exempt political groups was rejected.

  • · Director election votes - Gail K. Boudreaux: Against 1,714,229, Abstain 110,827
  • · Director election votes - Robert L. Dixon, Jr.: Against 5,590,793, Abstain 114,487
  • · Director election votes - Deanna D. Strable: Against 4,360,980, Abstain 110,967
  • · Executive compensation advisory vote: Against 7,240,619, Abstain 199,534
  • · Auditor ratification: Against 19,141,697, Abstain 116,310
  • · Shareholder proposal abstain: 1,292,319
IMMUCELL CORP /DE/ 10-K/A neutral materiality 3/10

13-05-2026

This 10-K/A amendment filed on May 13, 2026, updates Item 15 with exhibits including governance documents like bylaws amended September 20, 2024, and the 2025 Stock Option and Incentive Plan approved November 7, 2025. It lists material contracts such as development agreements with Norbrook Laboratories (amended through 2024), multiple lease amendments with TVP, LLC, executive compensation and employment agreements for Michael F. Brigham, Bobbi Jo Brockmann, Timothy C. Fiori, and Olivier te Boekhorst, and various debt instruments with Gorham Savings Bank, Maine Technology Institute, and Maine Community Bank. No financial performance data, period comparisons, or operational metrics are provided.

  • · Certificate of Amendment to Certificate of Incorporation effective June 11, 2020.
  • · Insider Trading Policy adopted December 11, 2024.
  • · Employment Agreement with Olivier te Boekhorst dated September 29, 2025.
Coca-Cola Consolidated, Inc. 8-K positive materiality 4/10

13-05-2026

Coca-Cola Consolidated, Inc. held its 2026 Annual Meeting of Stockholders on May 12, 2026. Stockholders elected all 11 director nominees to serve until the 2027 Annual Meeting, approved on an advisory basis the named executive officer compensation for fiscal 2025, and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2026. All proposals passed with strong majority support.

  • · Proxy statement filed with SEC on March 23, 2026
  • · Director election votes ranged from 213,970,839 (J. Frank Harrison, III For) to 235,204,142 (Jason D. (J.D.) Hickey For), with withheld votes up to 21,801,856
  • · Executive compensation advisory vote: 234,374,546 For, 1,288,975 Against, 109,174 Abstentions
  • · Auditor ratification: 242,857,325 For, 752,186 Against, 89,266 Abstentions
ARROW ELECTRONICS, INC. 8-K neutral materiality 6/10

13-05-2026

Arrow Electronics, Inc. restated its Certificate of Incorporation, deleting the prior Article TENTH that required a 90% affirmative vote of shareholders for certain actions and adding a new Article TENTH requiring only a majority vote, along with ministerial changes. The amendments were unanimously recommended by the board and approved by shareholders at a meeting on May 12, 2026, with a majority vote for most changes and two-thirds for the new voting threshold. The restated certificate authorizes 162,000,000 total shares: 2,000,000 shares of Preferred Stock and 160,000,000 shares of Common Stock, each with $1 par value.

  • · Original Certificate of Incorporation filed November 20, 1946.
  • · Amendments effected under Sections 803(a) and 807 of the New York Business Corporation Law.
  • · No preemptive rights for shareholders on new stock issuances.
TELA Bio, Inc. 10-Q mixed materiality 7/10

13-05-2026

TELA Bio reported Q1 2026 revenue of $19,059, up 3% YoY from $18,520, with gross profit remaining nearly flat at $12,520. However, net loss widened to $12,273 from $11,264 YoY due to higher operating expenses ($23,046 vs $22,984) and interest expense, while cash and equivalents fell to $39,541 from $50,845 QoQ and stockholders' equity shifted to a $5,201 deficit from $6,313.

  • · Inventory excess and obsolescence charge increased to $935 in Q1 2026 from $630 in Q1 2025.
  • · Proceeds from the sale of product line were $309 in Q1 2026 vs $170 in Q1 2025.
  • · Accounts receivable, net decreased to $9,715 as of March 31, 2026 from $10,347 as of December 31, 2025.
HF Sinclair Corp 8-K negative materiality 9/10

13-05-2026

HF Sinclair Corporation terminated the employment of Atanas Atanasov as Executive Vice President and Chief Financial Officer, effective immediately on May 13, 2026, after he had been on leave since February 24, 2026. Vivek Garg, the Company's Vice President, Chief Accounting Officer and Controller, has served as acting CFO since February 24, 2026. Atanasov may be eligible for severance benefits under the Company's Severance Pay Plan if conditions are met.

  • · Atanasov on leave since February 24, 2026, as reported in Form 10-K filed February 27, 2026.
  • · Severance Pay Plan details in Proxy Statement filed March 31, 2026.
ClearPoint Neuro, Inc. 8-K mixed materiality 9/10

13-05-2026

ClearPoint Neuro reported record Q1 2026 revenue of $12.1 million, up 43% YoY from $8.5 million, driven by 80% growth in neurosurgery navigation to $5.9 million and 177% in capital equipment to $1.4 million, with 25% organic growth in devices; however, biologics revenue grew only slightly to $4.8 million from $4.7 million, operating expenses rose 44% to $16.2 million due to personnel and integration costs from the IRRAS acquisition, and cash decreased to $35.6 million from $45.9 million at year-end amid $8.0 million operating cash burn. Gross margin improved to 64% from 60%. The company guides 2026 revenue to $52-56 million.

  • · Product revenue $8,802 thousand and service/other revenue $3,326 thousand in Q1 2026.
  • · Research and development costs $4,522 thousand, sales and marketing $6,715 thousand in Q1 2026.
  • · IRRAflow revenue contribution of $2.3 million in Q1 2026.
  • · Cash used in operating activities $8.0 million and $2.0 million in taxes in Q1 2026.
Insight Molecular Diagnostics Inc. 8-K/A positive materiality 6/10

13-05-2026

Insight Molecular Diagnostics Inc. (IMDX) entered into a Specimen Collection Agreement with Quest Diagnostics Incorporated on February 20, 2026, for specimen collection services related to its GraftAssureCoreTM test. This 8-K/A, filed on May 13, 2026, amends a prior Form 8-K by reclassifying the disclosure from Item 1.01 to Item 8.01 Other Events.

  • · GraftAssureCoreTM is a blood test designed to measure donor-derived cell free DNA (dd-cfDNA) using a novel PCR-based measurement platform.
  • · Company address: 2 International Plaza Dr., Suite 510, Nashville, Tennessee 37217.
  • · Trading symbol: IMDX on The Nasdaq Stock Market LLC.
COLGATE PALMOLIVE CO 8-K positive materiality 4/10

13-05-2026

Colgate-Palmolive Company held its Annual Meeting of Stockholders on May 8, 2026, electing all ten director nominees with strong majorities (For votes ranging from 580,860,042 to 630,748,353), though some faced notable opposition (e.g., John T. Cahill with 55,593,274 Against). Stockholders ratified PricewaterhouseCoopers LLP as the independent auditor for the year ending December 31, 2026 (647,385,500 For) and approved the non-binding advisory vote on executive compensation (591,185,556 For). Two stockholder proposals were rejected: 'Remove DEI from Board Candidate Considerations' (14,002,273 For vs. 618,251,142 Against) and 'Independent Board Chairman' (182,439,869 For vs. 452,415,385 Against).

  • · Broker non-votes: 63,952,735 across all director elections and proposals 3-5
  • · Auditor ratification abstentions: 1,204,733
  • · Executive compensation vote abstentions: 3,428,842
AEGIS FINANCIAL CORP 13F-HR neutral materiality 6/10

13-05-2026

Aegis Financial Corp filed its 13F-HR on May 13, 2026, reporting total holdings valued at $580477863 across 37 positions as of March 31, 2026, with no changes from the prior quarter. The portfolio focuses on energy, gold mining, and industrial companies, with top positions including Cenovus Energy Inc (91576811), Equinox Gold Corp (55875391), and Vermilion Energy Inc (35175129), all held solely. All 37 holdings have sole voting power and no reported shared power, puts, or calls.

  • · Filing effective date: May 13, 2026
  • · No changes in holdings (change indicator: 0)
  • · All positions reported with sole discretionary voting power (SH SOLE) and zero shared power, zero put options, zero call options
Ascend Wellness Holdings, Inc. 8-K mixed materiality 9/10

13-05-2026

Ascend Wellness Holdings reported Q1 2026 net revenue of $116.9 million, down 3.0% QoQ from $120.5 million due to post-holiday seasonality, weather-related closures, pricing pressures, and competition, with retail revenue declining 2.2% to $83.1 million and wholesale dropping 5.0% to $33.8 million. Adjusted Gross Profit Margin improved to 46.1% from 45.4%, Adjusted EBITDA was $26.3 million (down from $30.2 million, 22.5% margin), and net loss narrowed to $29.5 million from $48.7 million. Operational highlights include adding five dispensaries YTD to reach 51 locations, ranking #2 brand house in Illinois, Massachusetts, and New Jersey, and Q2 outlook for 2-3% revenue growth.

  • · Plans to expand to at least 60 dispensaries by end of 2026, subject to approvals.
  • · Temporarily suspending operations at Lansing, Michigan facility end of Q2 2026 for fire remediation; no material impact anticipated.
  • · Operates in Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania.
  • · Net cash outflow from operating activities: $19.4M in Q1 2026.
  • · High Wired ranked #1 infused flower brand across Illinois, Massachusetts, New Jersey in Q1 2026.
KROGER CO DEFA14A neutral materiality 7/10

13-05-2026

Kroger Co. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting on June 25, 2026, at 11:00 AM ET, held virtually at www.virtualshareholdermeeting.com/KR2026. Shareholders of record as of April 28, 2026, will vote on electing 10 director nominees (board recommends FOR all), advisory approval of executive compensation (FOR), ratification of PricewaterhouseCoopers LLP as auditors (FOR), and approval of the 2019 Second Amended and Restated Long-Term Incentive Plan (FOR), while the board recommends AGAINST a shareholder proposal for a report on GHG emissions reductions.

  • · Vote by June 24, 2026, 11:59 PM ET (or June 22 for shares in a Plan)
  • · Request proxy materials by June 11, 2026, via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
  • · Kroger address: 1014 Vine Street, Cincinnati, OH 45202
NEWMONT Corp /DE/ 8-K positive materiality 7/10

13-05-2026

Newmont Corporation held its 2026 Annual Meeting of Stockholders on May 12, 2026, where all 13 directors were elected with 97.41% to 99.68% votes for, the advisory resolution on executive compensation was approved with 92.52% support (7.23% against), and ratification of Ernst & Young LLP as independent auditors passed with 98.25% votes for (1.68% against). While all proposals received strong majority approval, executive compensation faced notable opposition at 7.23% against, and directors like Bruce R. Brook and Julio M. Quintana saw higher withheld votes at 3.96% and 2.59%, respectively.

  • · Abstentions excluded from director election tabulations but included in other proposals.
  • · Total votes cast on executive compensation: 819,810,158 shares.
  • · Total votes at auditor ratification: 879,772,792 shares.
Marvell Technology, Inc. DEFA14A neutral materiality 7/10

13-05-2026

Marvell Technology, Inc. filed a DEFA14A additional proxy statement for its 2026 Annual Meeting, outlining votes on the election of eight director nominees (Sara Andrews, Brad W. Buss, Daniel Durn, Rebecca W. House, Marachel L. Knight, Matthew J. Murphy, Rajiv Ramaswami, Richard P. Wallace), an advisory vote to approve named executive officer compensation, ratification of Deloitte and Touche LLP as independent auditors for the fiscal year ending January 30, 2027, and a stockholder proposal for an Independent Board Chairman. The board recommends FOR on items 1-3 and AGAINST on item 4. Voting must be completed by June 24, 2026 11:59 PM ET, with materials requestable by June 11, 2026 via www.ProxyVote.com, phone, or email.

  • · Meeting location: 1000 N. West Street Suite 1200, Wilmington, DE 19801
  • · This is not a votable ballot; follow instructions on reverse side or vote at www.ProxyVote.com
  • · NOTE: Such other business as may properly come before the meeting or any adjournment thereof
SentinelOne, Inc. DEF 14A neutral materiality 7/10

13-05-2026

SentinelOne, Inc. filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 25, 2026, at 9:00 a.m. Pacific Time. Key proposals include electing Class II directors to serve until the 2029 annual meeting, ratifying Deloitte & Touche LLP as independent auditors for the fiscal year ending January 31, 2027, and an advisory vote to approve named executive officer compensation. The record date is April 30, 2026, with 335,181,654 shares of Class A common stock and 6,300,444 shares of Class B common stock outstanding.

  • · Annual Meeting access: www.virtualshareholdermeeting.com/S2026 using control number from proxy card or Notice
  • · Proxy materials mailed on or about May 13, 2026
  • · Fiscal year ends January 31; references to fiscal 2027 (ending January 31, 2027), fiscal 2026 (ended January 31, 2026)
KRONOS WORLDWIDE INC 8-K positive materiality 6/10

13-05-2026

KRONOS Worldwide, Inc. held its 2026 annual meeting of stockholders on May 13, 2026, with stockholders representing 93.2% of the 115,053,116 eligible shares present in person or by proxy. All eight director nominees were elected, each receiving at least 85.6% of votes in favor, and the non-binding say-on-pay proposal was approved by 86.3% of eligible shares. A press release was furnished under Item 7.01 (Exhibit 99.1).

  • · Definitive proxy statement on Schedule 14A filed with SEC on March 24, 2026.
  • · Securities: Common Stock (KRO) on New York Stock Exchange.
Aptera Motors Corp 10-Q mixed materiality 7/10

13-05-2026

Aptera Motors Corp reported no revenues in Q1 2026, posting a net loss of $10,194 thousand (improved 6% YoY from $10,867 thousand) due to lower G&A expenses ($4,427 thousand vs $7,948 thousand), though R&D expenses rose sharply to $5,905 thousand (up 84% YoY). Cash and equivalents increased 84% QoQ to $17,721 thousand, supported by $16,042 thousand in financing proceeds, boosting stockholders' equity to $29,644 thousand from $20,440 thousand; however, net cash used in operations worsened to $7,890 thousand from $3,559 thousand YoY.

  • · Class B common shares increased from 15,718,440 to 24,573,741 during Q1 2026 via sales, exercises, and conversions.
  • · Unearned reservation fees remained stable at approximately $4,080 thousand QoQ.
  • · Subscription receivables cleared to $0 from ($131) thousand.
  • · Weighted average remaining lease term 2.0 years as of March 31, 2026 (up from 1.25 years at Dec 31, 2025).
Marvell Technology, Inc. DEF 14A neutral materiality 6/10

13-05-2026

Marvell Technology, Inc.'s 2026 Proxy Statement details the virtual Annual Meeting on June 25, 2026, to elect eight directors (reducing Board size from nine due to Mr. Brown's retirement), approve named executive officer compensation on an advisory basis, ratify Deloitte & Touche LLP as auditors for fiscal year ending January 30, 2027, and vote on a stockholder proposal for an Independent Board Chairman (Board recommends AGAINST). As of the April 30, 2026 record date, 875,553,173 common shares and 2,000,000 Series A Convertible Preferred shares (convertible to 21,778,000 common shares) are outstanding, totaling 897,331,173 voting shares on an as-converted basis. The Board nominees include Chairman & CEO Matthew J. Murphy and seven independent directors.

  • · Annual Meeting at 9:00 a.m. Pacific Time, virtual via www.virtualshareholdermeeting.com/MRVL2026.
  • · Record date: close of business 6:00 p.m. Pacific Time on April 30, 2026.
  • · Series A Preferred Stock does not vote for election and removal of directors.
  • · Proxy materials available at www.proxyvote.com.
  • · Fiscal 2026 ended January 31, 2026; fiscal 2027 ends January 30, 2027.
Aptera Motors Corp 8-K mixed materiality 8/10

13-05-2026

Aptera Motors reported Q1 2026 GAAP net loss of $10.2 million, an improvement from $10.9 million YoY, but adjusted net loss widened to $6.2 million from $4.8 million, with operating expenses declining to $10.3 million from $11.2 million. The company secured $17.1 million in new capital, ending the quarter with $17.7 million in cash and cash equivalents (up from $10.7 million), grew headcount 54% YoY to 57 employees, and resolved Zaptera litigation via a $0.6 million non-cash settlement. Post-quarter, it drove the first five validation vehicles off its low-volume assembly line.

  • · Weighted-average shares outstanding increased to 32,145,836 in Q1 2026 from 23,377,204 in Q1 2025.
  • · Maintains access to equity line of credit (ELOC), subject to customary conditions.
KROGER CO DEF 14A positive materiality 8/10

13-05-2026

Kroger's 2026 DEF 14A Proxy Statement includes letters from CEO Gregory S. Foran and Chairman Ronald L. Sargent emphasizing strong 2025 performance with nearly doubled identical sales without fuel, 9% EPS growth, $16B eCommerce sales achieving profitability, and 403,000 associates serving 11 million daily customers. The company plans 30% growth in new stores for 2026 alongside efficiency improvements and investments in affordability and technology. Voting matters include election of directors (all recommended FOR except shareholder proposal AGAINST), advisory approval of NEO compensation, auditor ratification, and LTIP approval.

  • · Kroger founded 143 years ago
  • · Proxy voting recommendations: FOR director elections, NEO compensation (advisory), auditors, LTIP; AGAINST shareholder proposal
  • · Corporate governance: All director nominees independent except CEO and Chairman; annual director elections; shareholders right to call special meetings; proxy access for 3% holders
  • · 2025 Community Service Award recipients from various divisions including Alana Serrette, Robyn Ware, Dick Foster, and others
Insight Molecular Diagnostics Inc. 10-Q mixed materiality 8/10

13-05-2026

For Q1 2026, Insight Molecular Diagnostics Inc. reported net revenue of $32 thousand, a 98.5% YoY decline from $2,138 thousand, with gross profit falling to $15 thousand from $1,325 thousand. Despite higher R&D ($4,953 thousand vs $2,924 thousand) and sales/marketing expenses ($2,402 thousand vs $1,206 thousand), the net loss narrowed to $4,290 thousand from $6,671 thousand, aided by a $5,918 thousand gain from change in fair value of contingent consideration. Cash and equivalents rose to $28,201 thousand at quarter-end from $11,583 thousand at year-end 2025, boosted by $24,698 thousand net financing proceeds, though operating cash use worsened to $7,639 thousand from $5,839 thousand.

  • · Total assets increased to $40,427 thousand from $25,756 thousand QoQ.
  • · Total liabilities decreased to $51,118 thousand from $57,220 thousand QoQ.
  • · Shareholders’ deficit improved to ($10,691) thousand from ($31,464) thousand QoQ.
  • · Antidilutive potential common shares: 3,694 thousand in Q1 2026 vs 2,623 thousand in Q1 2025.
ECA Marcellus Trust I 10-Q mixed materiality 7/10

13-05-2026

For Q1 2026, ECA Marcellus Trust I reported royalty income of $1,792,578, up 40% YoY from $1,278,647, leading to distributable income of $1,583,025 (up 74% YoY) or $0.090 per unit (vs. $0.052). However, the Trust Corpus declined to $12,527,658 from $13,192,593 YoY due to amortization of $275,056 and distributions, while net royalty interest in gas properties fell 3% QoQ to $8,867,070. Total assets grew to $14,110,683 from $13,321,836 QoQ, supported by higher cash and receivables.

  • · Cash reserves withheld by Trustee: $90,000 (flat YoY)
  • · Interest withheld on cash reserves Q1 2026: $24,658 (down from $26,420 YoY)
  • · 17,605,000 common units authorized, issued and outstanding
AtlasClear Holdings, Inc. 10-Q mixed materiality 8/10

13-05-2026

AtlasClear Holdings reported total assets of $73,915,806 as of March 31, 2026, up 21% from $60,892,833 at June 30, 2025, driven by higher cash and cash equivalents ($16,706,099 vs $7,533,690), while liabilities decreased 24% to $51,657,227 from $67,690,281, turning stockholders' equity positive at $22,258,579 from a $6,797,448 deficit. Revenues grew 65% YoY to $4,201,852 in Q3 FY26 and 67% to $13,509,536 for 9M FY26; however, expenses surged 97% to $7,134,711 in Q3 and 76% to $19,774,955 for 9M, leading to a Q3 net loss of $1,930,884 (improved from $2,902,828) and 9M net income decline to $4,412,993 from $7,425,515, with operating cash use worsening to $4,998,995.

  • · Common shares outstanding increased to 149,794,297 from 40,165,603 due to conversions and issuances.
  • · Proceeds from Secured Convertible Notes: $10,000,000; Equity SPA net: $5,850,000 (gross) less $1,228,500 costs.
  • · Cash at end of 9M period: $41,172,003 vs $27,489,798 prior year.
Motorsport Games Inc. 10-Q mixed materiality 8/10

13-05-2026

For Q1 2026, Motorsport Games Inc. reported revenues of $4,031,289, a 129% YoY increase from $1,758,453, leading to gross profit of $3,514,152 (up 172% YoY) and operating income of $1,056,421 versus a $93,195 loss last year. However, net income attributable to the company declined 70% YoY to $315,827 from $1,041,058, due to higher general and administrative expenses ($1,698,631 vs $1,168,482) and other expenses of $101,643. Balance sheet showed total assets up 16% QoQ to $13,880,041, cash up 17% to $5,859,299, but liabilities rose 21% to $5,323,217 with increased warrants liability.

  • · Related party revenues: $11,000 in Q1 2026 vs $0 in Q1 2025.
  • · Impairment of intangible assets: $27,928 in Q1 2026 vs $0.
  • · Warrants and stock option liability increased to $1,191,521 from $798,188 QoQ.
  • · Non-controlling interest net income: $635,746 profit in Q1 2026 vs ($18,445) loss.
Motorsport Games Inc. 8-K mixed materiality 8/10

13-05-2026

Motorsport Games Inc. reported Q1 2026 revenues of $4.0 million, more than doubling YoY from $1.8 million (+129.3%), with gross profit rising to $3.5 million and margin expanding to 87.2% from 73.5%; Adjusted EBITDA improved to $1.5 million from $0.6 million. However, net income remained flat at approximately $1.0 million YoY ($951,573 vs. $1,022,613), and net income attributable to Class A common stock declined to $0.06 per share from $0.33. Post-period, cash decreased to $3.8 million from $5.9 million after a $3.7 million share repurchase of 904,395 shares from Driven Lifestyle Group LLC.

  • · Generated average positive cash flow from operations of $0.5 million per month in Q1 2026.
  • · Secured $3.0 million revolving line of credit with Citibank in February 2026; maturity extended to February 20, 2028 in May 2026.
  • · Le Mans Ultimate Version 1.3 released in March 2026, including new UI framework for console development.
NSTAR ELECTRIC CO 8-K neutral materiality 7/10

13-05-2026

NSTAR Electric Company, doing business as Eversource Energy, issued $350,000,000 aggregate principal amount of its 4.650% Debentures due May 15, 2031, and $350,000,000 aggregate principal amount of its 5.200% Debentures due May 15, 2036, on May 13, 2026. The Debentures were issued under an Underwriting Agreement dated May 11, 2026, with representatives including Goldman Sachs & Co. LLC, Mizuho Securities USA LLC, TD Securities (USA) LLC, U.S. Bancorp Investments, Inc., and Wells Fargo Securities, LLC. Interest on both series is payable semi-annually on May 15 and November 15, commencing November 15, 2026.

  • · Debentures issued under indenture dated September 1, 1988.
  • · Registered with SEC under Form S-3 (Commission File No. 333-286362-03).
MYOMO, INC. 8-K positive materiality 6/10

13-05-2026

Myomo, Inc. appointed Joseph M. Manko Jr., Senior Principal of Horton Capital Management LLC (a significant shareholder), as a director effective May 9, 2026, expanding the board to seven members until the 2027 annual meeting. Mr. Manko brings over 25 years of experience in investment banking, private equity, and asset management, with prior roles at BZ Fund Management, Deutsche Bank, Merrill Lynch, and as a corporate finance attorney at Skadden, Arps, Slate, Meagher & Flom. The appointment aims to support Myomo's growth strategy, Success Pillars for 2026, and long-term shareholder value.

  • · Mr. Manko currently serves on the boards of Safeguard Scientifics and Koru Medical Systems.
  • · Mr. Manko earned B.A. and Juris Doctor from the University of Pennsylvania.
  • · Myomo headquartered at 45 Blue Sky Dr., Suite 101, Burlington, MA 01803.
NEWELL BRANDS INC. 8-K positive materiality 6/10

13-05-2026

Newell Brands Inc. held its Annual Meeting of Stockholders on May 7, 2026, where all eight director nominees were elected with majority support ranging from 87% (Patrick D. Campbell) to 98% (Gerardo I. Lopez, Christopher H. Peterson, Anthony Terry). Stockholders ratified PricewaterhouseCoopers LLP as auditors (99% support), approved Say-On-Pay (78% support despite 22% opposition), and approved the 2026 Incentive Plan (93% support). Of 424,927,772 shares outstanding as of the March 12, 2026 record date, 368,135,426 shares were voted, with 41,561,938 broker non-votes.

  • · Director votes - Bridget Ryan Berman: 310,789,046 For, 15,433,058 Against, 351,384 Abstain
  • · Director votes - Patrick D. Campbell: 283,377,489 For, 42,822,754 Against, 373,245 Abstain
  • · Director votes - James P. Keane: 302,088,999 For, 24,084,176 Against, 400,313 Abstain
  • · Director votes - Gerardo I. Lopez: 320,436,005 For, 5,707,674 Against, 429,809 Abstain
  • · Director votes - Christopher H. Peterson: 321,807,657 For, 4,437,197 Against, 328,634 Abstain
  • · Director votes - Gary H. Pilnick: 302,428,045 For, 23,717,278 Against, 428,165 Abstain
  • · Director votes - Stephanie P. Stahl: 299,906,682 For, 26,222,825 Against, 443,981 Abstain
  • · Director votes - Anthony Terry: 321,216,034 For, 4,883,089 Against, 474,365 Abstain
  • · Auditor ratification: 363,199,115 For, 4,359,352 Against, 576,959 Abstain
  • · Say-On-Pay: 254,464,829 For, 71,068,404 Against, 1,040,255 Abstain
  • · 2026 Incentive Plan: 305,206,680 For, 20,662,767 Against, 704,041 Abstain
  • · Proxy Statement filed March 26, 2026
Allegiant Travel CO 8-K positive materiality 10/10

13-05-2026

Allegiant Travel Company (ALGT) completed its acquisition of Sun Country Airlines Holdings, Inc. (SNCY) on May 13, 2026, forming a leading U.S. leisure-focused airline with a combined fleet of 195 aircraft serving nearly 175 cities, 22 million annual customers, and more than 650 routes. The transaction is expected to deliver approximately $140 million in annual synergies within three years, driven by scale efficiencies, fleet optimization, and procurement benefits, and to be accretive to earnings per share in the first full year post-closing. Both airlines will operate separately in the near term with no immediate changes to customer reservations, flight schedules, or frontline roles, though integration risks including potential delays, higher costs, and operational challenges are highlighted.

  • · Sun Country common stock ceased trading on NASDAQ post-closing.
  • · Minneapolis-St. Paul to remain an important operating center.
  • · Sun Country’s charter contracts include casinos, Major League Soccer, collegiate sports teams, and Department of Defense.
  • · All existing collective bargaining agreements remain in place.
BlackRock ESG Capital Allocation Term Trust DEFA14A positive materiality 8/10

13-05-2026

BlackRock ESG Capital Allocation Term Trust (ECAT) has issued additional proxy materials for a contested board election, urging shareholders to vote FOR its Class I, II, and III trustee nominees on the WHITE proxy card to avoid significant changes to the fund. The board highlights ECAT's strong performance since inception, including growth of a $10,000 investment to $19,272 as of April 30, 2026 (outperforming peer median of $15,566), 233% growth in monthly payout distribution rate target as a % of NAV, and the #1 lowest discount to NAV among competitor funds. No underperformance or declines are noted in the materials.

  • · Performance data sourced from Morningstar Closed-End Tactical Allocation category median (excluding BlackRock funds) as of April 30, 2026.
  • · Shareholders can vote online, by phone, or mail using the WHITE card; prior votes from other cards can be superseded.
  • · Contact BlackRock proxy solicitor Georgeson LLC at 1-866-961-8444 for questions.
  • · Fund inception name change date: May 27, 2021; fiscal year end: December 31.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Consumer Staples Sector SEC Filings

🇺🇸 More from United States

View all →